8
Views
0
CrossRef citations to date
0
Altmetric
Articles

Evaluating a National Dissemination Approach: The National Cancer Institute's Clinical Trials Education Program

, , , , , & show all
Pages 49-57 | Published online: 06 Mar 2009
 

Abstract

Background. Adult participation in clinical trials is low, and many individuals are unaware of trials as an option. Raising awareness about clinical trials and addressing barriers through education is key to increasing enrollment in trials. Methods. To reach communities, the National Cancer Institute (NCI) worked with partners to disseminate clinical trials education resources. Evaluation was conducted to determine the effectiveness of the dissemination approaches on program goals. Results. Survey results indicated that partners disseminated, used, and were satisfied with the program resources. Focus group results corroborated these findings. Conclusions. NCI's program successfully used partnerships for broad dissemination of resources to improve clinical trials awareness.

ACKNOWLEDGMENTS

The authors would like to acknowledge the reviewers of this article (Harry Kwon, Rose Mary Padberg, and Andrea Denicoff) and the 176 Clinical Trials Education Program partners. We are especially grateful to the NCI's Cancer Information Service staff with whom we collaborated in the development, dissemination, and evaluation of this program. For more information on the Clinical Trials Education Series, go to http://www.cancer.gov/clinicaltrials/learning/clinical-trials-education-series. To learn more about NCI's Cancer Information Service visit http://cis.nci.nih.gov/.

Log in via your institution

Log in to Taylor & Francis Online

There are no offers available at the current time.

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.